Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 1;35(5):434-439.
doi: 10.1097/GCO.0000000000000902. Epub 2023 Aug 17.

Perioperative hormone treatment of endometriosis

William Farkas  1 , Alexandros Lazaridis  2 , Funlayo Odejinmi  3 , Martin Hirsch  1
Affiliations

Perioperative hormone treatment of endometriosis

William Farkas et al. Curr Opin Obstet Gynecol. .

Abstract

Purpose of review: The use of hormonally suppressive medication to reduce levels of reproductive hormones around the time of surgery is widely used in the management of endometriosis. This review summarizes the current evidence concerning the perioperative use of hormonal treatment in the management of endometriosis.

Recent findings: European Society of Human Reproduction and Embryology (ESHRE) guidanceSurgical Outcomes and Complications of Laparoscopic Hysterectomy for Endometriosis: A Multicentre Cohort StudyPre and postsurgical medical therapy for endometriosis surgery. Cochrane 2020Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis. BJOG 2021.

Summary: The literature highlights the importance of hormonal treatment for symptom relief, reduced surgical complications and postoperative benefits, including a reduction in pain, disease recurrence and improved pregnancy rates. The treatment of endometriosis can be broadly categorized into medical, commonly using hormonal suppression medications and surgical, in which endometriosis tissue is excised or ablated. This review aims to outline current management strategies and examines the relationship between the two treatment modalities.

PubMed Disclaimer

References

    1. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet 2021; 397:839–852.
    1. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open [Internet] 2022; 2022:hoac009.
    1. Cromeens MG, Carey ET, Robinson WR, et al. Timing, delays and pathways to diagnosis of endometriosis: a scoping review protocol. BMJ Open 2021; 11:e049390.
    1. National Guideline Alliance (UK). Endometriosis: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2017. PMID: 29787038.
    1. Rafique S, Decherney AH. Medical management of endometriosis. Clin Obstet Gynecol 2017; 60:485–496.

Publication types